$XPL
Solitario Resources Corp Stock $xpl

$xpl Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000165495423010345 Filed on August 09, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$282.0K	$315.0K
YoY Change	-35.17%	13.72%
% of Gross Profit
Research & Development	$918.0K	$555.0K
YoY Change	40.15%	-41.64%
% of Gross Profit
Depreciation & Amortization	$7.000K	$6.000K
YoY Change	0.0%	-25.0%
% of Gross Profit
Operating Expenses	$1.207M	$876.0K
YoY Change	10.03%	-29.13%
Operating Profit
YoY Change
Interest Expense	-$85.00K	-$164.0K
YoY Change	-302.38%	-59.8%
% of Operating Profit
Other Income/Expense, Net	-$85.00K	-$164.0K
YoY Change	-312.5%	-63.96%
Pretax Income	-$1.292M	-$1.040M
YoY Change	22.23%	-38.5%
Income Tax
% Of Pretax Income
Net Earnings	-$1.292M	-$1.040M
YoY Change	22.23%	-38.5%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.02
Diluted Earnings Per Share	-$0.02	-$0.02
COMMON SHARES
Basic Shares Outstanding	69.52M shares	64.80M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.042M	$3.624M
YoY Change	321.22%	944.56%
Cash & Equivalents	$168.0K	$496.0K
Short-Term Investments	$4.874M	$3.128M
Other Short-Term Assets	$237.0K	$366.0K
YoY Change	540.54%	351.85%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$5.279M	$3.990M
YoY Change	-13.91%	-44.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.83M	$16.84M
YoY Change	-0.05%	2.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.000K	$4.000K
YoY Change	-97.32%	-97.58%
Total Long-Term Assets	$16.83M	$16.85M
YoY Change	-0.05%	2.21%
TOTAL ASSETS
Total Short-Term Assets	$5.279M	$3.990M
Total Long-Term Assets	$16.83M	$16.85M
Total Assets	$22.11M	$20.84M
YoY Change	-3.75%	-12.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$295.0K	$235.0K
YoY Change	-47.97%	-52.04%
Accrued Expenses	$31.00K	$31.00K
YoY Change	-26.19%	-26.19%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$327.0K	$274.0K
YoY Change	-46.31%	-48.5%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$185.0K	$195.0K
YoY Change	43.41%	40.29%
Total Long-Term Liabilities	$185.0K	$195.0K
YoY Change	43.41%	40.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$327.0K	$274.0K
Total Long-Term Liabilities	$185.0K	$195.0K
Total Liabilities	$512.0K	$469.0K
YoY Change	-30.62%	-30.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$56.60M	-$55.31M
YoY Change	6.35%	6.03%
Common Stock	$692.0K	$649.0K
YoY Change	6.79%	0.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$21.60M	$20.37M
YoY Change
Total Liabilities & Shareholders Equity	$22.11M	$20.84M
YoY Change	-3.75%	-12.16%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$1.292M	-$1.040M
YoY Change	22.23%	-38.5%
Depreciation, Depletion And Amortization	$7.000K	$6.000K
YoY Change	0.0%	-25.0%
Cash From Operating Activities	-$919.0K	-$1.080M
YoY Change	35.95%	60.0%
INVESTING ACTIVITIES
Capital Expenditures	$3.000K	$9.000K
YoY Change	-100.8%	-118.37%
Acquisitions
YoY Change
Other Investing Activities	-$1.873M	$1.131M
YoY Change	-297.16%	56.22%
Cash From Investing Activities	-$1.876M	$1.122M
YoY Change	-426.83%	66.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.467M	14.00K
YoY Change		1300.0%
NET CHANGE
Cash From Operating Activities	-919.0K	-1.080M
Cash From Investing Activities	-1.876M	1.122M
Cash From Financing Activities	2.467M	14.00K
Net Change In Cash	-328.0K	56.00K
YoY Change	221.57%	5500.0%
FREE CASH FLOW
Cash From Operating Activities	-$919.0K	-$1.080M
Capital Expenditures	$3.000K	$9.000K
Free Cash Flow	-$922.0K	-$1.089M
YoY Change	207.33%	73.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	1236000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1420000	usd
CY2023Q2	sodi	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	64807000	shares
CY2022Q2	sodi	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	64769000	shares
	sodi	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	64804000	shares
CY2022Q4	sodi	Investments In Marketable Equity Securities At Fair Value InvestmentsInMarketableEquitySecuritiesAtFairValue	949000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	366000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	3990000	usd
CY2023Q2	us-gaap	Mineral Properties Net MineralPropertiesNet	16646000	usd
CY2023Q2	us-gaap	Assets Assets	20835000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	235000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	649000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	75025000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000917225
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64801373	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64851373	shares
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39278
	dei	Entity Registrant Name EntityRegistrantName	SOLITARIO RESOURCES CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1285791
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4251 Kipling St. Suite 390
	dei	Entity Address City Or Town EntityAddressCityOrTown	Wheat Ridge
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80033
	dei	City Area Code CityAreaCode	303
	dei	Local Phone Number LocalPhoneNumber	534-1030
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
	dei	Trading Symbol TradingSymbol	XPL
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	69518040	shares
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	496000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	316000	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	2077000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	3951000	usd
CY2023Q2	sodi	Investments In Marketable Equity Securities At Fair Value InvestmentsInMarketableEquitySecuritiesAtFairValue	1051000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	38000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	5254000	usd
CY2022Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	16646000	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	199000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	134000	usd
CY2022Q4	us-gaap	Assets Assets	22034000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	228000	usd
CY2023Q2	sodi	Kinross Call Option Current KinrossCallOptionCurrent	8000	usd
CY2022Q4	sodi	Kinross Call Option Current KinrossCallOptionCurrent	0	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	35000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	274000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	263000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	70000	usd
CY2023Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	125000	usd
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	125000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	195000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	125000	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64851373	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64801373	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	648000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	74886000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-55308000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-53888000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	20366000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	21646000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20835000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22034000	usd
CY2023Q2	us-gaap	Exploration Expense ExplorationExpense	555000	usd
CY2022Q2	us-gaap	Exploration Expense ExplorationExpense	951000	usd
	us-gaap	Exploration Expense ExplorationExpense	830000	usd
	us-gaap	Exploration Expense ExplorationExpense	1177000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	12000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	315000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	277000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	791000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	664000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	876000	usd
	us-gaap	Operating Expenses OperatingExpenses	1633000	usd
	us-gaap	Operating Expenses OperatingExpenses	1857000	usd
CY2023Q2	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	26000	usd
CY2022Q2	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	41000	usd
	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	53000	usd
	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	68000	usd
CY2023Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	23000	usd
CY2022Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-3000	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	23000	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-4000	usd
CY2023Q2	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	usd
CY2022Q2	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-78000	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-159000	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	14000	usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-47000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	35000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-98000	usd
CY2023Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-227000	usd
CY2022Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-368000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	102000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-155000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-164000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-455000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	213000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-348000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1040000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1691000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2205000	usd
CY2023Q2	sodi	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	-0.02
CY2022Q2	sodi	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	-0.03
	sodi	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	-0.02
	sodi	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	-0.03
	sodi	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	63748000	shares
	us-gaap	Profit Loss ProfitLoss	-1420000	usd
	us-gaap	Profit Loss ProfitLoss	-2205000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	12000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	20000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	20000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	102000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-155000	usd
	sodi	Unrealized Gain Loss On Short Term Investments UnrealizedGainLossOnShortTermInvestments	-35000	usd
	sodi	Unrealized Gain Loss On Short Term Investments UnrealizedGainLossOnShortTermInvestments	98000	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	126000	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	26000	usd
	sodi	Loss On Sale Of Marketable Equity Securities LossOnSaleOfMarketableEquitySecurities	0	usd
	sodi	Loss On Sale Of Marketable Equity Securities LossOnSaleOfMarketableEquitySecurities	159000	usd
	sodi	Gain Loss On Derivative Instruments GainLossOnDerivativeInstruments	23000	usd
	sodi	Gain Loss On Derivative Instruments GainLossOnDerivativeInstruments	-3000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-328000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	222000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-15000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	234000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1765000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1272000	usd
	sodi	Purchase Sale Of Short Term Investments Net PurchaseSaleOfShortTermInvestmentsNet	1909000	usd
	sodi	Purchase Sale Of Short Term Investments Net PurchaseSaleOfShortTermInvestmentsNet	-881000	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-10000	usd
	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	9000	usd
	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	49000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	53000	usd
	sodi	Sale Of Derivative Instruments Net SaleOfDerivativeInstrumentsNet	31000	usd
	sodi	Sale Of Derivative Instruments Net SaleOfDerivativeInstrumentsNet	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1931000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-887000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2023000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	14000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	20000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2043000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	180000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-116000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	316000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	462000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	496000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	346000	usd
	sodi	Acquisition Of Right To Use Asset AcquisitionOfRightToUseAsset	87000	usd
	sodi	Acquisition Of Right To Use Asset AcquisitionOfRightToUseAsset	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:left;">Solitario faces risks related to health epidemics and other outbreaks of communicable diseases, which could significantly disrupt its operations and may materially and adversely affect its business and financial condition.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:left;">Solitario’s business still could be adversely impacted by the effects of the coronavirus (“COVID-19”) or other epidemics or pandemics. Although the COVID-19 public health emergency was officially terminated in May 2023, Solitario will continue to evaluate the effects of any resurgence of COVID-19 or other health events on its operations and, as Solitario did at times during the pandemic, will take proactive steps to address the impacts on its operations, including reducing costs, in response to the economic uncertainty associated with potential risks. Solitairo has also evaluated the potential impacts of market volatility, general economic uncertainty, and rising geopolitical tension on its ability to access future traditional funding sources on the same or reasonably similar terms as in past periods. Solitario will continue to monitor the effects of these risks on its operations, financial condition, and liquidity. However, the extent to which these risks ultimately impact Solitario’s business, including its exploration and other activities and the market for its securities, will depend on future developments, which are highly uncertain and cannot be predicted at this time.</p>
CY2023Q2	sodi	Cash And Cash Equivalents Held In Brokerage Accounts And Foreign Banks CashAndCashEquivalentsHeldInBrokerageAccountsAndForeignBanks	380000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	10000	usd
CY2023Q2	us-gaap	Us Government Securities At Carrying Value USGovernmentSecuritiesAtCarryingValue	2077000	usd
	sodi	Maturities Period Of Current Assets In United States Treasury Securities MaturitiesPeriodOfCurrentAssetsInUnitedStatesTreasurySecurities	30 days to 8 months
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5340000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5390000	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5341250	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5440000	shares
CY2023Q2	us-gaap	Mineral Properties Net MineralPropertiesNet	16646000	usd
CY2022Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	16646000	usd
CY2023Q2	us-gaap	Exploration Expense ExplorationExpense	555000	usd
CY2022Q2	us-gaap	Exploration Expense ExplorationExpense	951000	usd
	us-gaap	Exploration Expense ExplorationExpense	830000	usd
	us-gaap	Exploration Expense ExplorationExpense	1177000	usd
CY2023Q2	sodi	Investments In Marketable Equity Securities At Fair Value InvestmentsInMarketableEquitySecuritiesAtFairValue	1051000	usd
CY2022Q4	sodi	Investments In Marketable Equity Securities At Fair Value InvestmentsInMarketableEquitySecuritiesAtFairValue	949000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P26M
CY2023Q2	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	1440000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	1440000	usd
CY2023Q2	sodi	Unrealized Gain Loss On Marketable Equity Securities UnrealizedGainLossOnMarketableEquitySecurities	-389000	usd
CY2022Q4	sodi	Unrealized Gain Loss On Marketable Equity Securities UnrealizedGainLossOnMarketableEquitySecurities	-491000	usd
CY2023Q2	sodi	Investments In Marketable Equity Securities At Fair Value InvestmentsInMarketableEquitySecuritiesAtFairValue	1051000	usd
CY2022Q4	sodi	Investments In Marketable Equity Securities At Fair Value InvestmentsInMarketableEquitySecuritiesAtFairValue	949000	usd
CY2023Q2	sodi	Cost Of Marketable Equity Securities Sold CostOfMarketableEquitySecuritiesSold	0	usd
CY2022Q2	sodi	Cost Of Marketable Equity Securities Sold CostOfMarketableEquitySecuritiesSold	105000	usd
	sodi	Cost Of Marketable Equity Securities Sold CostOfMarketableEquitySecuritiesSold	0	usd
	sodi	Cost Of Marketable Equity Securities Sold CostOfMarketableEquitySecuritiesSold	212000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	0	usd
CY2022Q2	sodi	Realized Gain On Marketable Equity Securities Sold RealizedGainOnMarketableEquitySecuritiesSold	-78000	usd
	sodi	Realized Gain On Marketable Equity Securities Sold RealizedGainOnMarketableEquitySecuritiesSold	0	usd
	sodi	Realized Gain On Marketable Equity Securities Sold RealizedGainOnMarketableEquitySecuritiesSold	-159000	usd
CY2023Q2	sodi	Realized Gain On Marketable Equity Securities Sold RealizedGainOnMarketableEquitySecuritiesSold	0	usd
CY2022Q2	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	27000	usd
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	0	usd
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	53000	usd
CY2023Q2	sodi	Net Gain Losses On Marketable Securities NetGainLossesOnMarketableSecurities	-227000	usd
CY2022Q2	sodi	Net Gain Losses On Marketable Securities NetGainLossesOnMarketableSecurities	-446000	usd
	sodi	Net Gain Losses On Marketable Securities NetGainLossesOnMarketableSecurities	-102000	usd
	sodi	Net Gain Losses On Marketable Securities NetGainLossesOnMarketableSecurities	-314000	usd
CY2023Q2	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	-227000	usd
CY2022Q2	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	-473000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	-102000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	-367000	usd
CY2023Q2	sodi	Unrealized Gain On Marketable Equity Securities UnrealizedGainOnMarketableEquitySecurities	-227000	usd
CY2022Q2	sodi	Unrealized Gain On Marketable Equity Securities UnrealizedGainOnMarketableEquitySecurities	-368000	usd
	sodi	Unrealized Gain On Marketable Equity Securities UnrealizedGainOnMarketableEquitySecurities	-102000	usd
	sodi	Unrealized Gain On Marketable Equity Securities UnrealizedGainOnMarketableEquitySecurities	-155000	usd
CY2023Q2	sodi	Realized Gain On Marketable Equity Securities Sold RealizedGainOnMarketableEquitySecuritiesSold	0	usd
CY2022Q2	sodi	Realized Gain On Marketable Equity Securities Sold RealizedGainOnMarketableEquitySecuritiesSold	-78000	usd
	sodi	Realized Gain On Marketable Equity Securities Sold RealizedGainOnMarketableEquitySecuritiesSold	0	usd
	sodi	Realized Gain On Marketable Equity Securities Sold RealizedGainOnMarketableEquitySecuritiesSold	-159000	usd
CY2023Q2	sodi	Net Gain Losses On Marketable Securities NetGainLossesOnMarketableSecurities	-227000	usd
CY2022Q2	sodi	Net Gain Losses On Marketable Securities NetGainLossesOnMarketableSecurities	-446000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	21646000	usd
CY2023Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	67000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-380000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	21333000	usd
CY2023Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	59000	usd
CY2022Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	13000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1040000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	20366000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23183000	usd
CY2022Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	13000	usd
CY2022Q1	sodi	Issuance Of Shares At Net Value IssuanceOfSharesAtNetValue	2023000	usd
	sodi	Net Gain Losses On Marketable Securities NetGainLossesOnMarketableSecurities	-102000	usd
	sodi	Net Gain Losses On Marketable Securities NetGainLossesOnMarketableSecurities	-314000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	14000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	44000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	45000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	111000	usd
CY2023Q2	us-gaap	Interest Portion Of Minimum Lease Payments Sale Leaseback Transactions InterestPortionOfMinimumLeasePaymentsSaleLeasebackTransactions	10000	usd
CY2023Q2	sodi	Present Value Of Leases Payments PresentValueOfLeasesPayments	101000	usd
CY2023Q2	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	11000	usd
CY2022Q2	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	8000	usd
	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	22000	usd
	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	18000	usd
CY2023Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	87000	usd
CY2022Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	87000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	199000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	134000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	19000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-514000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	24724000	usd
CY2022Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	13000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1691000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	23047000	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	2077000	usd
CY2023Q2	sodi	Investments In Marketable Equity Securities At Fair Value InvestmentsInMarketableEquitySecuritiesAtFairValue	1051000	usd
CY2023Q2	sodi	Kinross Call Option Current KinrossCallOptionCurrent	8000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	3951000	usd
CY2022Q4	sodi	Investments In Marketable Equity Securities At Fair Value InvestmentsInMarketableEquitySecuritiesAtFairValue	949000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	492000	usd

Files In Submission

Name	View Source	Status
0001654954-23-010345-index-headers.html	Edgar Link	pending
0001654954-23-010345-index.html	Edgar Link	pending
0001654954-23-010345.txt	Edgar Link	pending
0001654954-23-010345-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sodi-20230630.xsd	Edgar Link	pending
sodi_10q.htm	Edgar Link	pending
sodi_ex311.htm	Edgar Link	pending
sodi_ex312.htm	Edgar Link	pending
sodi_ex321.htm	Edgar Link	pending
sodi_ex41.htm	Edgar Link	pending
sodi_ex41img1.jpg	Edgar Link	pending
sodi_ex41img2.jpg	Edgar Link	pending
sodi-20230630_def.xml	Edgar Link	unprocessable
sodi-20230630_pre.xml	Edgar Link	unprocessable
sodi_10q_htm.xml	Edgar Link	completed
sodi-20230630_cal.xml	Edgar Link	unprocessable
sodi-20230630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XPL
Solitario Resources Corp Stock $xpl

2023 Q3 Form 10-Q Financial Statement

#000165495423010345 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XPL Solitario Resources Corp Stock $xpl

2023 Q3 Form 10-Q Financial Statement

#000165495423010345 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XPL
Solitario Resources Corp Stock $xpl